Biocatalytic conversions using E. coli transketolase variants have been developed for the efficient, scalable synthesis of l - gluco -heptulose from the sustainable starting material l -arabinose.
No takes yet. Share an insight, caveat, or question.
Subrizi et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: